2006 NF Consortium for NF1, NF2 and Schwannomatosis

2006 NF1、NF2 和神经鞘瘤病联盟

• 批准号: 7162767
• 负责人: VIJAYA RAMESH
• 金额: $ 3.05万
• 依托单位: CHILDREN'S TUMOR FOUNDATION
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-07-15 至 2007-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7162767
• 关键词: meeting /conference /symposium; neurofibromatosis

DESCRIPTION (provided by applicant): This application requests funding support for the 2006 annual meeting of the Children's Tumor Foundation International Consortium for the Molecular and Cell Biology of NF1, NF2 and Schwannomatosis. The Meeting will be held June 4-7, 2006, at the Hotel Jerome in Aspen, Colorado. This annual meeting has had a fruitful history since its inception in 1985, and it plays a lynchpin role as the premier annual gathering of researchers and clinicians in the NF community. The meeting is a forum for research information exchange and discussion for researchers from around the world, and has traditionally fostered collaboration, consensus building, and advances in translational research culminating in clinical trials. This is a time of tremendous advances in NF research on many fronts from basic through clinical, and this is reflected in the theme of the 2006 meeting - "Progress: From Bench to Bedside". Five individual sessions will take the Consortium from molecular mechanisms of NF through translational models to clinical therapies. Speakers will include both junior and senior researchers. In keeping with the bench to bedside theme, for the first time select sessions will include a few words from a patient advocate whose life is affected by NF. Each session will also include a keynote address by a leading investigator from outside of NF research to open up broad ranging discussions. Competitive travel awards will bring young investigators for oral presentations, and 2 poster sessions will allow investigators to present their work to the NF community. In 2006 we are taking two new approaches in order to increase the visibility of this meeting and of the state of NF research. Firstly to increase industry awareness of NF we will seek fiscal sponsorship for this meeting from a large number of pharmaceutical companies. Incentive sponsorships will be offered at diamond, platinum, gold and silver levels. Secondly, the co-chairs and the Foundation will work together to seek publication of a Consortium Report in a peer-reviewed journal. This will promote to the research community at large the status of NF research, the link with other cancers and neurological disorders and the key barriers to be addressed.

描述（由申请人提供）：本申请请求为儿童肿瘤基金会国际 NF1、NF2 和神经鞘瘤病分子和细胞生物学联合会 2006 年年会提供资金支持。 会议将于 2006 年 6 月 4 日至 7 日在科罗拉多州阿斯彭的杰罗姆酒店举行。 该年会自 1985 年创办以来已经取得了丰硕的历史，作为 NF 界研究人员和临床医生的首要年度聚会发挥着关键作用。 该会议是世界各地研究人员交流和讨论研究信息的论坛，传统上促进了合作、建立共识和转化研究的进展，最终导致临床试验。 这是从基础到临床的许多前沿领域 NF 研究取得巨大进步的时代，这反映在 2006 年会议的主题“进步：从实验室到临床”中。 五场单独的会议将让联盟从神经纤维瘤的分子机制到转化模型再到临床治疗。 演讲者将包括初级和高级研究人员。 为了与从工作台到床边的主题保持一致，精选的会议将首次包括生活受到 NF 影响的患者倡导者的几句话。 每场会议还将包括来自 NF 研究之外的主要研究人员的主题演讲，以展开广泛的讨论。 竞争性旅行奖励将让年轻的研究人员进行口头报告，两次海报会议将允许研究人员向 NF 社区展示他们的工作。 2006 年，我们采取了两种新方法来提高本次会议和 NF 研究状况的知名度。 首先，为了提高行业对 NF 的认识，我们将向众多制药公司寻求本次会议的财政赞助。 奖励赞助将分为钻石级、白金级、黄金级和白银级。 其次，联合主席和基金会将共同努力寻求在同行评审期刊上发表联盟报告。 这将向整个研究界宣传 NF 研究的地位、与其他癌症和神经系统疾病的联系以及需要解决的关键障碍。